2014
DOI: 10.1088/1758-5082/6/2/025001
|View full text |Cite
|
Sign up to set email alerts
|

Manufacture of β-TCP/alginate scaffolds through a Fab@home model for application in bone tissue engineering

Abstract: The growing need to treat bone-related diseases in an elderly population compels the development of novel bone substitutes to improve patient quality of life. In this context, the advent of affordable and effective rapid prototyping equipment, such as the Fab@home plotter, has contributed to the development of novel scaffolds for bone tissue engineering. In this study, we report for the first time the use of a Fab@home plotter for the production of 3D scaffolds composed by beta-tricalcium phosphate (β-TCP)/alg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
23
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(27 citation statements)
references
References 47 publications
3
23
0
Order By: Relevance
“…The z-stacked 3D images show cell penetration in a 50 μm section of the scaffold (images c and d in Figure 6). Similar patterns of cell penetration and cell distribution were observed previously by fibroblasts seeded in alginate/β-TCP composite scaffolds [36]. …”
Section: Resultssupporting
confidence: 82%
“…The z-stacked 3D images show cell penetration in a 50 μm section of the scaffold (images c and d in Figure 6). Similar patterns of cell penetration and cell distribution were observed previously by fibroblasts seeded in alginate/β-TCP composite scaffolds [36]. …”
Section: Resultssupporting
confidence: 82%
“…Absorbance intensity, which is directly proportional to metabolic activity, was measured at 492 nm using a microplate reader (SYNERGY HT, BIO-TEK, Winooski, VT, USA). The results are the mean of three independent experiments ( n = 3) with 3 replicates for each condition and per experiment [42]. …”
Section: Methodsmentioning
confidence: 99%
“…Good biocompatibility requires that the scaffold material has good surface physicochemical properties to ensure normal adhesion and growth of the cells; the scaffold does not cause inflammatory reaction, any immunogenicity and cytotoxicity, and the degradation rate should be related to tissue growth. The speed is consistent, achieving a smooth transition from the stent to the ontogenesis [9,10]. In addition, during the degradation of the scaffold, the tissue cells are provided with a constantly changing interface for adhesion and growth, which contributes to the firm adhesion of the cells to the material.…”
Section: Biocompatibilitymentioning
confidence: 85%